229 related articles for article (PubMed ID: 28329322)
21. Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapy.
Barra S; Looi KL; Gajendragadkar PR; Khan FZ; Virdee M; Agarwal S
Europace; 2016 Aug; 18(8):1187-93. PubMed ID: 26566940
[TBL] [Abstract][Full Text] [Related]
22. Incidence, predictors, and outcomes associated with pneumothorax during cardiac electronic device implantation: A 16-year review in over 3.7 million patients.
Ogunbayo GO; Charnigo R; Darrat Y; Morales G; Kotter J; Olorunfemi O; Elbadawi A; Sorrell VL; Smyth SS; Elayi CS
Heart Rhythm; 2017 Dec; 14(12):1764-1770. PubMed ID: 28735733
[TBL] [Abstract][Full Text] [Related]
23. Device complications with addition of defibrillation to cardiac resynchronisation therapy for primary prevention.
Barra S; Providência R; Boveda S; Duehmke R; Narayanan K; Chow AW; Piot O; Klug D; Defaye P; Gras D; Deharo JC; Milliez P; Da Costa A; Mondoly P; Gonzalez-Panizo J; Leclercq C; Heck P; Virdee M; Sadoul N; Le Heuzey JY; Marijon E
Heart; 2018 Sep; 104(18):1529-1535. PubMed ID: 29540431
[TBL] [Abstract][Full Text] [Related]
24. Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian Registry.
Morani G; Gasparini M; Zanon F; Casali E; Spotti A; Reggiani A; Bertaglia E; Solimene F; Molon G; Accogli M; Tommasi C; Paoletti Perini A; Ciardiello C; Padeletti L
Europace; 2013 Sep; 15(9):1273-9. PubMed ID: 23439866
[TBL] [Abstract][Full Text] [Related]
25. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.
Gadler F; Valzania C; Linde C
Europace; 2015 Jan; 17(1):69-77. PubMed ID: 25336667
[TBL] [Abstract][Full Text] [Related]
26. Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator.
Martens P; Verbrugge FH; Nijst P; Dupont M; Nuyens D; Herendael HV; Rivero-Ayerza M; Tang WH; Mullens W
Heart; 2017 Dec; 103(24):1977-1984. PubMed ID: 28716973
[TBL] [Abstract][Full Text] [Related]
27. PR interval identifies clinical response in patients with non-left bundle branch block: a Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy substudy.
Kutyifa V; Stockburger M; Daubert JP; Holmqvist F; Olshansky B; Schuger C; Klein H; Goldenberg I; Brenyo A; McNitt S; Merkely B; Zareba W; Moss AJ
Circ Arrhythm Electrophysiol; 2014 Aug; 7(4):645-51. PubMed ID: 24963007
[TBL] [Abstract][Full Text] [Related]
28. The Effect of Chronic Kidney Disease on Mortality with Cardiac Resynchronization Therapy.
Daly DD; Maran A; Hyer JM; Funke F; Waring A; Cuoco FA; Sturdivant JL; Leman RB; Gold MR
Pacing Clin Electrophysiol; 2016 Aug; 39(8):863-9. PubMed ID: 27197959
[TBL] [Abstract][Full Text] [Related]
29. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
[TBL] [Abstract][Full Text] [Related]
30. Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy.
Biton Y; Kutyifa V; Cygankiewicz I; Goldenberg I; Klein H; McNitt S; Polonsky B; Ruwald AC; Ruwald MH; Moss AJ; Zareba W
Circ Heart Fail; 2016 Feb; 9(2):e002667. PubMed ID: 26823498
[TBL] [Abstract][Full Text] [Related]
31. Coronary Venous Dissection from Left Ventricular Lead Placement During Cardiac Resynchronization Therapy With Defibrillator Implantation and Associated in-Hospital Adverse Events (from the NCDR ICD Registry).
Hsu JC; Varosy PD; Bao H; Dewland TA; Curtis JP; Marcus GM
Am J Cardiol; 2018 Jan; 121(1):55-61. PubMed ID: 29102348
[TBL] [Abstract][Full Text] [Related]
32. Sex-Related Procedural Aspects and Complications in CRT Survey II: A Multicenter European Experience in 11,088 Patients.
Auricchio A; Gasparini M; Linde C; Dobreanu D; Cano Ó; Sterlinski M; Bogale N; Stellbrink C; Refaat MM; Blomström-Lundqvist C; Lober C; Dickstein K; Normand C
JACC Clin Electrophysiol; 2019 Sep; 5(9):1048-1058. PubMed ID: 31537334
[TBL] [Abstract][Full Text] [Related]
33. Inverse Relationship of Blood Pressure to Long-Term Outcomes and Benefit of Cardiac Resynchronization Therapy in Patients With Mild Heart Failure: A Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Long-Term Follow-Up Substudy.
Biton Y; Moss AJ; Kutyifa V; Mathias A; Sherazi S; Zareba W; McNitt S; Polonsky B; Barsheshet A; Brown MW; Goldenberg I
Circ Heart Fail; 2015 Sep; 8(5):921-6. PubMed ID: 26179186
[TBL] [Abstract][Full Text] [Related]
34. Impact of cardiac resynchronization therapy on hospitalizations in the Resynchronization-Defibrillation for Ambulatory Heart Failure trial.
Gillis AM; Kerr CR; Philippon F; Newton G; Talajic M; Froeschl M; Froeschl S; Swiggum E; Yetisir E; Wells GA; Tang AS
Circulation; 2014 May; 129(20):2021-30. PubMed ID: 24610807
[TBL] [Abstract][Full Text] [Related]
35. The European Cardiac Resynchronization Therapy Survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades.
Bogale N; Witte K; Priori S; Cleland J; Auricchio A; Gadler F; Gitt A; Limbourg T; Linde C; Dickstein K;
Eur J Heart Fail; 2011 Sep; 13(9):974-83. PubMed ID: 21771823
[TBL] [Abstract][Full Text] [Related]
36. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark.
Kirkfeldt RE; Johansen JB; Nohr EA; Jørgensen OD; Nielsen JC
Eur Heart J; 2014 May; 35(18):1186-94. PubMed ID: 24347317
[TBL] [Abstract][Full Text] [Related]
37. Clinical outcomes in cardiac resynchronization therapy-defibrillator recipients 80 years of age and older.
Adelstein EC; Liu J; Jain S; Schwartzman D; Althouse AD; Wang NC; Gorcsan J; Saba S
Europace; 2016 Mar; 18(3):420-7. PubMed ID: 26487669
[TBL] [Abstract][Full Text] [Related]
38. Incidence, predictors, and procedural results of upgrade to resynchronization therapy: the RAFT upgrade substudy.
Essebag V; Joza J; Birnie DH; Sapp JL; Sterns LD; Philippon F; Yee R; Crystal E; Kus T; Rinne C; Healey JS; Sami M; Thibault B; Exner DV; Coutu B; Simpson CS; Wulffhart Z; Yetisir E; Wells G; Tang AS
Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):152-8. PubMed ID: 25417892
[TBL] [Abstract][Full Text] [Related]
39. Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE).
Gold MR; Daubert JC; Abraham WT; Hassager C; Dinerman JL; Hudnall JH; Cerkvenik J; Linde C
Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1163-8. PubMed ID: 24125796
[TBL] [Abstract][Full Text] [Related]
40. Comparative Effectiveness of CRT-D Versus Defibrillator Alone in HF Patients With Moderate-to-Severe Chronic Kidney Disease.
Friedman DJ; Singh JP; Curtis JP; Tang WHW; Bao H; Spatz ES; Hernandez AF; Patel UD; Al-Khatib SM
J Am Coll Cardiol; 2015 Dec; 66(23):2618-2629. PubMed ID: 26670062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
